Global Fertility Treatments Market

Fertility Treatments Comprehensive Study by Type (Equipment (Microscopes, Sperm Analyzer Systems, Imaging Systems, Micromanipulators Systems, Ovum Aspiration Pumps, Cryosystems, Incubators, Gas Analyzers, and Laser Systems), Consumables, Accessories), End Users (Hospitals & Surgical Clinics, Fertility Centers, Research Institutes, Cryobanks), Sex (Male, Female), Procedure (Assisted Reproductive Technology (Vitro Fertilization, Surrogacy, and Intra-Cytoplasmic Sperm Injection (ICSI)), Artificial Insemination (Intrauterine Insemination, Intracervical Insemination, and Intratubal Insemination), Fertility Surgery (Myomectomy, Laparoscopy, Hysteroscopy, Varicocelectomy, Laparotomy, Tubal Ligation Reversal, and Microsurgical Reconstruction), Others), Diagnostic Centers (Men Diagnostic Tests, Women Diagnostic, General Diagnostic Tests) Players and Region - Global Market Outlook to 2030

Fertility Treatments Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 8.1%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Fertility Treatments Market Scope
Infertility can be defined as the inability of an individual to breed by natural means. The causes of infertility are very diverse. It can be due to advancement of maternal age, disorders in the occurrence of biological process, tubal occlusion or blockage, genetics, sexually transmitted infections, immune infertility, endometrial polyps, uterine fibroids, infertility due to male factors, endometriosis, and others. Fertility rate has halved since 1960. Treatment choices for infertility include education or spreading awareness, medications to assist the development of egg during the ovulation period, insemination, in vitro fertilization (IVF), and third party reproduction surgery.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
Key Companies ProfiledCook Group Incorporated (United States), Esco Micro Pte. Ltd. (Singapore), Genea Limited (Australia), Hamilton Throne, Ltd. (United States), Ihmedical (United States), Irvine Scientific (United States), IVFTech Aps (Denmark), Kitazato Corporation (Japan), Medgyn Products, Inc. (United States), Rocket Medical PLC (United Kingdom) and Somatex Medical Technologies GmbH (Germany)
CAGR8.1%


There are various companies that are exploring the market opportunities by investing in the new treatment and also expanding their footprints in new geographic regions by adopting various strategic initiatives such as mergers & acquisitions, expansions, investments, new product launches, and others. Research Analyst at AMA estimates that Global Players will contribute to the maximum growth of Global Fertility Treatments market throughout the predicted period.

Cook Group Incorporated (United States), Esco Micro Pte. Ltd. (Singapore), Genea Limited (Australia), Hamilton Throne, Ltd. (United States), Ihmedical (United States), Irvine Scientific (United States), IVFTech Aps (Denmark), Kitazato Corporation (Japan), Medgyn Products, Inc. (United States), Rocket Medical PLC (United Kingdom) and Somatex Medical Technologies GmbH (Germany) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are The Baker Company, Inc. (United States), The Cooper Companies, Inc. (United States), Thermo Fisher Scientific (United States), Vitrolife Ab (Sweden) and Zeiss Group (Germany).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Fertility Treatments market by Type and Region with country level break-up.

On the basis of geography, the market of Fertility Treatments has been segmented into South America (Brazil, Argentina, Chile, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Singapore, Indonesia, Thailand, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Spain, Sweden, Belgium, Finland, Denmark, Russia, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2023.

Market Leaders and their expansionary development strategies
In August 2023, Maven Clinic, the world's largest virtual clinic for women's and family health, announced it has partnered with Amazon to expand Amazon's family-building support program across the world to 50 countries outside the US and Canada, and is available to full-time, part-time and hourly employees. Working together, Maven and Amazon will give Amazon employees and their partners free access, via Maven, to board-certified reproductive endocrinologists (fertility doctors), obstetricians, gynecologists, nutritionists, mental health providers, adoption coaches, and other care providers.
In May 2203, Merck, a leading science and technology company, today launched a new initiative, Fertility Counts, which seeks to address the social, economic and societal challenges associated with low birth rates in the Asia-Pacific (APAC) region. The initiative is designed to provide research and resources to support policymakers in identifying policy interventions that will be effective in building family-friendly societies.


Influencing Trend:
Surging Development and Commercialization of Hormonal Therapy

Market Growth Drivers:
Declining Fertility Rate, Increasing Awareness Among People, Increasing Disposable Income, Rising Adoption of Assisted Reproductive Technologies (ART) and Growing Sedentary Lifestyle across the Globe

Challenges:
Impact of Repeated Failures in Treatments

Restraints:
High Cost of Procedures and Social Taboos

Opportunities:
Governments Initiatives to Improve the Reimbursement Scenario for Infertility-related Treatments and Increasing Healthcare Expenditure in Developing Countries

Key Target Audience
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Male Infertility Treatment Provider, Government Regulatory and Research Organizations and End-Use Industries

Report Objectives / Segmentation Covered

By Type
  • Equipment (Microscopes, Sperm Analyzer Systems, Imaging Systems, Micromanipulators Systems, Ovum Aspiration Pumps, Cryosystems, Incubators, Gas Analyzers, and Laser Systems)
  • Consumables
  • Accessories
By End Users
  • Hospitals & Surgical Clinics
  • Fertility Centers
  • Research Institutes
  • Cryobanks

By Sex
  • Male
  • Female

By Procedure
  • Assisted Reproductive Technology (Vitro Fertilization, Surrogacy, and Intra-Cytoplasmic Sperm Injection (ICSI))
  • Artificial Insemination (Intrauterine Insemination, Intracervical Insemination, and Intratubal Insemination)
  • Fertility Surgery (Myomectomy, Laparoscopy, Hysteroscopy, Varicocelectomy, Laparotomy, Tubal Ligation Reversal, and Microsurgical Reconstruction)
  • Others

By Diagnostic Centers
  • Men Diagnostic Tests
  • Women Diagnostic
  • General Diagnostic Tests

By Regions
  • South America
    • Brazil
    • Argentina
    • Chile
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Indonesia
    • Thailand
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Spain
    • Sweden
    • Belgium
    • Finland
    • Denmark
    • Russia
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Declining Fertility Rate
      • 3.2.2. Increasing Awareness Among People
      • 3.2.3. Increasing Disposable Income
      • 3.2.4. Rising Adoption of Assisted Reproductive Technologies (ART)
      • 3.2.5. Growing Sedentary Lifestyle across the Globe
    • 3.3. Market Challenges
      • 3.3.1. Impact of Repeated Failures in Treatments
    • 3.4. Market Trends
      • 3.4.1. Surging Development and Commercialization of Hormonal Therapy
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Fertility Treatments, by Type, End Users, Sex, Procedure, Diagnostic Centers and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Fertility Treatments (Value)
      • 5.2.1. Global Fertility Treatments by: Type (Value)
        • 5.2.1.1. Equipment (Microscopes, Sperm Analyzer Systems, Imaging Systems, Micromanipulators Systems, Ovum Aspiration Pumps, Cryosystems, Incubators, Gas Analyzers, and Laser Systems)
        • 5.2.1.2. Consumables
        • 5.2.1.3. Accessories
      • 5.2.2. Global Fertility Treatments by: End Users (Value)
        • 5.2.2.1. Hospitals & Surgical Clinics
        • 5.2.2.2. Fertility Centers
        • 5.2.2.3. Research Institutes
        • 5.2.2.4. Cryobanks
      • 5.2.3. Global Fertility Treatments by: Sex (Value)
        • 5.2.3.1. Male
        • 5.2.3.2. Female
      • 5.2.4. Global Fertility Treatments by: Procedure (Value)
        • 5.2.4.1. Assisted Reproductive Technology (Vitro Fertilization, Surrogacy, and Intra-Cytoplasmic Sperm Injection (ICSI))
        • 5.2.4.2. Artificial Insemination (Intrauterine Insemination, Intracervical Insemination, and Intratubal Insemination)
        • 5.2.4.3. Fertility Surgery (Myomectomy, Laparoscopy, Hysteroscopy, Varicocelectomy, Laparotomy, Tubal Ligation Reversal, and Microsurgical Reconstruction)
        • 5.2.4.4. Others
      • 5.2.5. Global Fertility Treatments by: Diagnostic Centers (Value)
        • 5.2.5.1. Men Diagnostic Tests
        • 5.2.5.2. Women Diagnostic
        • 5.2.5.3. General Diagnostic Tests
      • 5.2.6. Global Fertility Treatments Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Chile
          • 5.2.6.1.4. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Singapore
          • 5.2.6.2.6. Indonesia
          • 5.2.6.2.7. Thailand
          • 5.2.6.2.8. Australia
          • 5.2.6.2.9. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Spain
          • 5.2.6.3.7. Sweden
          • 5.2.6.3.8. Belgium
          • 5.2.6.3.9. Finland
          • 5.2.6.3.10. Denmark
          • 5.2.6.3.11. Russia
          • 5.2.6.3.12. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
  • 6. Fertility Treatments: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Cook Group Incorporated (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Esco Micro Pte. Ltd. (Singapore)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Genea Limited (Australia)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Hamilton Throne, Ltd. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Ihmedical (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Irvine Scientific (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. IVFTech Aps (Denmark)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Kitazato Corporation (Japan)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Medgyn Products, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Rocket Medical PLC (United Kingdom)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Somatex Medical Technologies GmbH (Germany)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Fertility Treatments Sale, by Type, End Users, Sex, Procedure, Diagnostic Centers and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Fertility Treatments (Value)
      • 7.2.1. Global Fertility Treatments by: Type (Value)
        • 7.2.1.1. Equipment (Microscopes, Sperm Analyzer Systems, Imaging Systems, Micromanipulators Systems, Ovum Aspiration Pumps, Cryosystems, Incubators, Gas Analyzers, and Laser Systems)
        • 7.2.1.2. Consumables
        • 7.2.1.3. Accessories
      • 7.2.2. Global Fertility Treatments by: End Users (Value)
        • 7.2.2.1. Hospitals & Surgical Clinics
        • 7.2.2.2. Fertility Centers
        • 7.2.2.3. Research Institutes
        • 7.2.2.4. Cryobanks
      • 7.2.3. Global Fertility Treatments by: Sex (Value)
        • 7.2.3.1. Male
        • 7.2.3.2. Female
      • 7.2.4. Global Fertility Treatments by: Procedure (Value)
        • 7.2.4.1. Assisted Reproductive Technology (Vitro Fertilization, Surrogacy, and Intra-Cytoplasmic Sperm Injection (ICSI))
        • 7.2.4.2. Artificial Insemination (Intrauterine Insemination, Intracervical Insemination, and Intratubal Insemination)
        • 7.2.4.3. Fertility Surgery (Myomectomy, Laparoscopy, Hysteroscopy, Varicocelectomy, Laparotomy, Tubal Ligation Reversal, and Microsurgical Reconstruction)
        • 7.2.4.4. Others
      • 7.2.5. Global Fertility Treatments by: Diagnostic Centers (Value)
        • 7.2.5.1. Men Diagnostic Tests
        • 7.2.5.2. Women Diagnostic
        • 7.2.5.3. General Diagnostic Tests
      • 7.2.6. Global Fertility Treatments Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Chile
          • 7.2.6.1.4. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Singapore
          • 7.2.6.2.6. Indonesia
          • 7.2.6.2.7. Thailand
          • 7.2.6.2.8. Australia
          • 7.2.6.2.9. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Spain
          • 7.2.6.3.7. Sweden
          • 7.2.6.3.8. Belgium
          • 7.2.6.3.9. Finland
          • 7.2.6.3.10. Denmark
          • 7.2.6.3.11. Russia
          • 7.2.6.3.12. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Fertility Treatments: by Type(USD Million)
  • Table 2. Fertility Treatments Equipment (Microscopes, Sperm Analyzer Systems, Imaging Systems, Micromanipulators Systems, Ovum Aspiration Pumps, Cryosystems, Incubators, Gas Analyzers, and Laser Systems) , by Region USD Million (2018-2023)
  • Table 3. Fertility Treatments Consumables , by Region USD Million (2018-2023)
  • Table 4. Fertility Treatments Accessories , by Region USD Million (2018-2023)
  • Table 5. Fertility Treatments: by End Users(USD Million)
  • Table 6. Fertility Treatments Hospitals & Surgical Clinics , by Region USD Million (2018-2023)
  • Table 7. Fertility Treatments Fertility Centers , by Region USD Million (2018-2023)
  • Table 8. Fertility Treatments Research Institutes , by Region USD Million (2018-2023)
  • Table 9. Fertility Treatments Cryobanks , by Region USD Million (2018-2023)
  • Table 10. Fertility Treatments: by Sex(USD Million)
  • Table 11. Fertility Treatments Male , by Region USD Million (2018-2023)
  • Table 12. Fertility Treatments Female , by Region USD Million (2018-2023)
  • Table 13. Fertility Treatments: by Procedure(USD Million)
  • Table 14. Fertility Treatments Assisted Reproductive Technology (Vitro Fertilization, Surrogacy, and Intra-Cytoplasmic Sperm Injection (ICSI)) , by Region USD Million (2018-2023)
  • Table 15. Fertility Treatments Artificial Insemination (Intrauterine Insemination, Intracervical Insemination, and Intratubal Insemination) , by Region USD Million (2018-2023)
  • Table 16. Fertility Treatments Fertility Surgery (Myomectomy, Laparoscopy, Hysteroscopy, Varicocelectomy, Laparotomy, Tubal Ligation Reversal, and Microsurgical Reconstruction) , by Region USD Million (2018-2023)
  • Table 17. Fertility Treatments Others , by Region USD Million (2018-2023)
  • Table 18. Fertility Treatments: by Diagnostic Centers(USD Million)
  • Table 19. Fertility Treatments Men Diagnostic Tests , by Region USD Million (2018-2023)
  • Table 20. Fertility Treatments Women Diagnostic , by Region USD Million (2018-2023)
  • Table 21. Fertility Treatments General Diagnostic Tests , by Region USD Million (2018-2023)
  • Table 22. South America Fertility Treatments, by Country USD Million (2018-2023)
  • Table 23. South America Fertility Treatments, by Type USD Million (2018-2023)
  • Table 24. South America Fertility Treatments, by End Users USD Million (2018-2023)
  • Table 25. South America Fertility Treatments, by Sex USD Million (2018-2023)
  • Table 26. South America Fertility Treatments, by Procedure USD Million (2018-2023)
  • Table 27. South America Fertility Treatments, by Diagnostic Centers USD Million (2018-2023)
  • Table 28. Brazil Fertility Treatments, by Type USD Million (2018-2023)
  • Table 29. Brazil Fertility Treatments, by End Users USD Million (2018-2023)
  • Table 30. Brazil Fertility Treatments, by Sex USD Million (2018-2023)
  • Table 31. Brazil Fertility Treatments, by Procedure USD Million (2018-2023)
  • Table 32. Brazil Fertility Treatments, by Diagnostic Centers USD Million (2018-2023)
  • Table 33. Argentina Fertility Treatments, by Type USD Million (2018-2023)
  • Table 34. Argentina Fertility Treatments, by End Users USD Million (2018-2023)
  • Table 35. Argentina Fertility Treatments, by Sex USD Million (2018-2023)
  • Table 36. Argentina Fertility Treatments, by Procedure USD Million (2018-2023)
  • Table 37. Argentina Fertility Treatments, by Diagnostic Centers USD Million (2018-2023)
  • Table 38. Chile Fertility Treatments, by Type USD Million (2018-2023)
  • Table 39. Chile Fertility Treatments, by End Users USD Million (2018-2023)
  • Table 40. Chile Fertility Treatments, by Sex USD Million (2018-2023)
  • Table 41. Chile Fertility Treatments, by Procedure USD Million (2018-2023)
  • Table 42. Chile Fertility Treatments, by Diagnostic Centers USD Million (2018-2023)
  • Table 43. Rest of South America Fertility Treatments, by Type USD Million (2018-2023)
  • Table 44. Rest of South America Fertility Treatments, by End Users USD Million (2018-2023)
  • Table 45. Rest of South America Fertility Treatments, by Sex USD Million (2018-2023)
  • Table 46. Rest of South America Fertility Treatments, by Procedure USD Million (2018-2023)
  • Table 47. Rest of South America Fertility Treatments, by Diagnostic Centers USD Million (2018-2023)
  • Table 48. Asia Pacific Fertility Treatments, by Country USD Million (2018-2023)
  • Table 49. Asia Pacific Fertility Treatments, by Type USD Million (2018-2023)
  • Table 50. Asia Pacific Fertility Treatments, by End Users USD Million (2018-2023)
  • Table 51. Asia Pacific Fertility Treatments, by Sex USD Million (2018-2023)
  • Table 52. Asia Pacific Fertility Treatments, by Procedure USD Million (2018-2023)
  • Table 53. Asia Pacific Fertility Treatments, by Diagnostic Centers USD Million (2018-2023)
  • Table 54. China Fertility Treatments, by Type USD Million (2018-2023)
  • Table 55. China Fertility Treatments, by End Users USD Million (2018-2023)
  • Table 56. China Fertility Treatments, by Sex USD Million (2018-2023)
  • Table 57. China Fertility Treatments, by Procedure USD Million (2018-2023)
  • Table 58. China Fertility Treatments, by Diagnostic Centers USD Million (2018-2023)
  • Table 59. Japan Fertility Treatments, by Type USD Million (2018-2023)
  • Table 60. Japan Fertility Treatments, by End Users USD Million (2018-2023)
  • Table 61. Japan Fertility Treatments, by Sex USD Million (2018-2023)
  • Table 62. Japan Fertility Treatments, by Procedure USD Million (2018-2023)
  • Table 63. Japan Fertility Treatments, by Diagnostic Centers USD Million (2018-2023)
  • Table 64. India Fertility Treatments, by Type USD Million (2018-2023)
  • Table 65. India Fertility Treatments, by End Users USD Million (2018-2023)
  • Table 66. India Fertility Treatments, by Sex USD Million (2018-2023)
  • Table 67. India Fertility Treatments, by Procedure USD Million (2018-2023)
  • Table 68. India Fertility Treatments, by Diagnostic Centers USD Million (2018-2023)
  • Table 69. South Korea Fertility Treatments, by Type USD Million (2018-2023)
  • Table 70. South Korea Fertility Treatments, by End Users USD Million (2018-2023)
  • Table 71. South Korea Fertility Treatments, by Sex USD Million (2018-2023)
  • Table 72. South Korea Fertility Treatments, by Procedure USD Million (2018-2023)
  • Table 73. South Korea Fertility Treatments, by Diagnostic Centers USD Million (2018-2023)
  • Table 74. Singapore Fertility Treatments, by Type USD Million (2018-2023)
  • Table 75. Singapore Fertility Treatments, by End Users USD Million (2018-2023)
  • Table 76. Singapore Fertility Treatments, by Sex USD Million (2018-2023)
  • Table 77. Singapore Fertility Treatments, by Procedure USD Million (2018-2023)
  • Table 78. Singapore Fertility Treatments, by Diagnostic Centers USD Million (2018-2023)
  • Table 79. Indonesia Fertility Treatments, by Type USD Million (2018-2023)
  • Table 80. Indonesia Fertility Treatments, by End Users USD Million (2018-2023)
  • Table 81. Indonesia Fertility Treatments, by Sex USD Million (2018-2023)
  • Table 82. Indonesia Fertility Treatments, by Procedure USD Million (2018-2023)
  • Table 83. Indonesia Fertility Treatments, by Diagnostic Centers USD Million (2018-2023)
  • Table 84. Thailand Fertility Treatments, by Type USD Million (2018-2023)
  • Table 85. Thailand Fertility Treatments, by End Users USD Million (2018-2023)
  • Table 86. Thailand Fertility Treatments, by Sex USD Million (2018-2023)
  • Table 87. Thailand Fertility Treatments, by Procedure USD Million (2018-2023)
  • Table 88. Thailand Fertility Treatments, by Diagnostic Centers USD Million (2018-2023)
  • Table 89. Australia Fertility Treatments, by Type USD Million (2018-2023)
  • Table 90. Australia Fertility Treatments, by End Users USD Million (2018-2023)
  • Table 91. Australia Fertility Treatments, by Sex USD Million (2018-2023)
  • Table 92. Australia Fertility Treatments, by Procedure USD Million (2018-2023)
  • Table 93. Australia Fertility Treatments, by Diagnostic Centers USD Million (2018-2023)
  • Table 94. Rest of Asia-Pacific Fertility Treatments, by Type USD Million (2018-2023)
  • Table 95. Rest of Asia-Pacific Fertility Treatments, by End Users USD Million (2018-2023)
  • Table 96. Rest of Asia-Pacific Fertility Treatments, by Sex USD Million (2018-2023)
  • Table 97. Rest of Asia-Pacific Fertility Treatments, by Procedure USD Million (2018-2023)
  • Table 98. Rest of Asia-Pacific Fertility Treatments, by Diagnostic Centers USD Million (2018-2023)
  • Table 99. Europe Fertility Treatments, by Country USD Million (2018-2023)
  • Table 100. Europe Fertility Treatments, by Type USD Million (2018-2023)
  • Table 101. Europe Fertility Treatments, by End Users USD Million (2018-2023)
  • Table 102. Europe Fertility Treatments, by Sex USD Million (2018-2023)
  • Table 103. Europe Fertility Treatments, by Procedure USD Million (2018-2023)
  • Table 104. Europe Fertility Treatments, by Diagnostic Centers USD Million (2018-2023)
  • Table 105. Germany Fertility Treatments, by Type USD Million (2018-2023)
  • Table 106. Germany Fertility Treatments, by End Users USD Million (2018-2023)
  • Table 107. Germany Fertility Treatments, by Sex USD Million (2018-2023)
  • Table 108. Germany Fertility Treatments, by Procedure USD Million (2018-2023)
  • Table 109. Germany Fertility Treatments, by Diagnostic Centers USD Million (2018-2023)
  • Table 110. France Fertility Treatments, by Type USD Million (2018-2023)
  • Table 111. France Fertility Treatments, by End Users USD Million (2018-2023)
  • Table 112. France Fertility Treatments, by Sex USD Million (2018-2023)
  • Table 113. France Fertility Treatments, by Procedure USD Million (2018-2023)
  • Table 114. France Fertility Treatments, by Diagnostic Centers USD Million (2018-2023)
  • Table 115. Italy Fertility Treatments, by Type USD Million (2018-2023)
  • Table 116. Italy Fertility Treatments, by End Users USD Million (2018-2023)
  • Table 117. Italy Fertility Treatments, by Sex USD Million (2018-2023)
  • Table 118. Italy Fertility Treatments, by Procedure USD Million (2018-2023)
  • Table 119. Italy Fertility Treatments, by Diagnostic Centers USD Million (2018-2023)
  • Table 120. United Kingdom Fertility Treatments, by Type USD Million (2018-2023)
  • Table 121. United Kingdom Fertility Treatments, by End Users USD Million (2018-2023)
  • Table 122. United Kingdom Fertility Treatments, by Sex USD Million (2018-2023)
  • Table 123. United Kingdom Fertility Treatments, by Procedure USD Million (2018-2023)
  • Table 124. United Kingdom Fertility Treatments, by Diagnostic Centers USD Million (2018-2023)
  • Table 125. Netherlands Fertility Treatments, by Type USD Million (2018-2023)
  • Table 126. Netherlands Fertility Treatments, by End Users USD Million (2018-2023)
  • Table 127. Netherlands Fertility Treatments, by Sex USD Million (2018-2023)
  • Table 128. Netherlands Fertility Treatments, by Procedure USD Million (2018-2023)
  • Table 129. Netherlands Fertility Treatments, by Diagnostic Centers USD Million (2018-2023)
  • Table 130. Spain Fertility Treatments, by Type USD Million (2018-2023)
  • Table 131. Spain Fertility Treatments, by End Users USD Million (2018-2023)
  • Table 132. Spain Fertility Treatments, by Sex USD Million (2018-2023)
  • Table 133. Spain Fertility Treatments, by Procedure USD Million (2018-2023)
  • Table 134. Spain Fertility Treatments, by Diagnostic Centers USD Million (2018-2023)
  • Table 135. Sweden Fertility Treatments, by Type USD Million (2018-2023)
  • Table 136. Sweden Fertility Treatments, by End Users USD Million (2018-2023)
  • Table 137. Sweden Fertility Treatments, by Sex USD Million (2018-2023)
  • Table 138. Sweden Fertility Treatments, by Procedure USD Million (2018-2023)
  • Table 139. Sweden Fertility Treatments, by Diagnostic Centers USD Million (2018-2023)
  • Table 140. Belgium Fertility Treatments, by Type USD Million (2018-2023)
  • Table 141. Belgium Fertility Treatments, by End Users USD Million (2018-2023)
  • Table 142. Belgium Fertility Treatments, by Sex USD Million (2018-2023)
  • Table 143. Belgium Fertility Treatments, by Procedure USD Million (2018-2023)
  • Table 144. Belgium Fertility Treatments, by Diagnostic Centers USD Million (2018-2023)
  • Table 145. Finland Fertility Treatments, by Type USD Million (2018-2023)
  • Table 146. Finland Fertility Treatments, by End Users USD Million (2018-2023)
  • Table 147. Finland Fertility Treatments, by Sex USD Million (2018-2023)
  • Table 148. Finland Fertility Treatments, by Procedure USD Million (2018-2023)
  • Table 149. Finland Fertility Treatments, by Diagnostic Centers USD Million (2018-2023)
  • Table 150. Denmark Fertility Treatments, by Type USD Million (2018-2023)
  • Table 151. Denmark Fertility Treatments, by End Users USD Million (2018-2023)
  • Table 152. Denmark Fertility Treatments, by Sex USD Million (2018-2023)
  • Table 153. Denmark Fertility Treatments, by Procedure USD Million (2018-2023)
  • Table 154. Denmark Fertility Treatments, by Diagnostic Centers USD Million (2018-2023)
  • Table 155. Russia Fertility Treatments, by Type USD Million (2018-2023)
  • Table 156. Russia Fertility Treatments, by End Users USD Million (2018-2023)
  • Table 157. Russia Fertility Treatments, by Sex USD Million (2018-2023)
  • Table 158. Russia Fertility Treatments, by Procedure USD Million (2018-2023)
  • Table 159. Russia Fertility Treatments, by Diagnostic Centers USD Million (2018-2023)
  • Table 160. Rest of Europe Fertility Treatments, by Type USD Million (2018-2023)
  • Table 161. Rest of Europe Fertility Treatments, by End Users USD Million (2018-2023)
  • Table 162. Rest of Europe Fertility Treatments, by Sex USD Million (2018-2023)
  • Table 163. Rest of Europe Fertility Treatments, by Procedure USD Million (2018-2023)
  • Table 164. Rest of Europe Fertility Treatments, by Diagnostic Centers USD Million (2018-2023)
  • Table 165. MEA Fertility Treatments, by Country USD Million (2018-2023)
  • Table 166. MEA Fertility Treatments, by Type USD Million (2018-2023)
  • Table 167. MEA Fertility Treatments, by End Users USD Million (2018-2023)
  • Table 168. MEA Fertility Treatments, by Sex USD Million (2018-2023)
  • Table 169. MEA Fertility Treatments, by Procedure USD Million (2018-2023)
  • Table 170. MEA Fertility Treatments, by Diagnostic Centers USD Million (2018-2023)
  • Table 171. Middle East Fertility Treatments, by Type USD Million (2018-2023)
  • Table 172. Middle East Fertility Treatments, by End Users USD Million (2018-2023)
  • Table 173. Middle East Fertility Treatments, by Sex USD Million (2018-2023)
  • Table 174. Middle East Fertility Treatments, by Procedure USD Million (2018-2023)
  • Table 175. Middle East Fertility Treatments, by Diagnostic Centers USD Million (2018-2023)
  • Table 176. Africa Fertility Treatments, by Type USD Million (2018-2023)
  • Table 177. Africa Fertility Treatments, by End Users USD Million (2018-2023)
  • Table 178. Africa Fertility Treatments, by Sex USD Million (2018-2023)
  • Table 179. Africa Fertility Treatments, by Procedure USD Million (2018-2023)
  • Table 180. Africa Fertility Treatments, by Diagnostic Centers USD Million (2018-2023)
  • Table 181. North America Fertility Treatments, by Country USD Million (2018-2023)
  • Table 182. North America Fertility Treatments, by Type USD Million (2018-2023)
  • Table 183. North America Fertility Treatments, by End Users USD Million (2018-2023)
  • Table 184. North America Fertility Treatments, by Sex USD Million (2018-2023)
  • Table 185. North America Fertility Treatments, by Procedure USD Million (2018-2023)
  • Table 186. North America Fertility Treatments, by Diagnostic Centers USD Million (2018-2023)
  • Table 187. United States Fertility Treatments, by Type USD Million (2018-2023)
  • Table 188. United States Fertility Treatments, by End Users USD Million (2018-2023)
  • Table 189. United States Fertility Treatments, by Sex USD Million (2018-2023)
  • Table 190. United States Fertility Treatments, by Procedure USD Million (2018-2023)
  • Table 191. United States Fertility Treatments, by Diagnostic Centers USD Million (2018-2023)
  • Table 192. Canada Fertility Treatments, by Type USD Million (2018-2023)
  • Table 193. Canada Fertility Treatments, by End Users USD Million (2018-2023)
  • Table 194. Canada Fertility Treatments, by Sex USD Million (2018-2023)
  • Table 195. Canada Fertility Treatments, by Procedure USD Million (2018-2023)
  • Table 196. Canada Fertility Treatments, by Diagnostic Centers USD Million (2018-2023)
  • Table 197. Mexico Fertility Treatments, by Type USD Million (2018-2023)
  • Table 198. Mexico Fertility Treatments, by End Users USD Million (2018-2023)
  • Table 199. Mexico Fertility Treatments, by Sex USD Million (2018-2023)
  • Table 200. Mexico Fertility Treatments, by Procedure USD Million (2018-2023)
  • Table 201. Mexico Fertility Treatments, by Diagnostic Centers USD Million (2018-2023)
  • Table 202. Company Basic Information, Sales Area and Its Competitors
  • Table 203. Company Basic Information, Sales Area and Its Competitors
  • Table 204. Company Basic Information, Sales Area and Its Competitors
  • Table 205. Company Basic Information, Sales Area and Its Competitors
  • Table 206. Company Basic Information, Sales Area and Its Competitors
  • Table 207. Company Basic Information, Sales Area and Its Competitors
  • Table 208. Company Basic Information, Sales Area and Its Competitors
  • Table 209. Company Basic Information, Sales Area and Its Competitors
  • Table 210. Company Basic Information, Sales Area and Its Competitors
  • Table 211. Company Basic Information, Sales Area and Its Competitors
  • Table 212. Company Basic Information, Sales Area and Its Competitors
  • Table 213. Fertility Treatments: by Type(USD Million)
  • Table 214. Fertility Treatments Equipment (Microscopes, Sperm Analyzer Systems, Imaging Systems, Micromanipulators Systems, Ovum Aspiration Pumps, Cryosystems, Incubators, Gas Analyzers, and Laser Systems) , by Region USD Million (2025-2030)
  • Table 215. Fertility Treatments Consumables , by Region USD Million (2025-2030)
  • Table 216. Fertility Treatments Accessories , by Region USD Million (2025-2030)
  • Table 217. Fertility Treatments: by End Users(USD Million)
  • Table 218. Fertility Treatments Hospitals & Surgical Clinics , by Region USD Million (2025-2030)
  • Table 219. Fertility Treatments Fertility Centers , by Region USD Million (2025-2030)
  • Table 220. Fertility Treatments Research Institutes , by Region USD Million (2025-2030)
  • Table 221. Fertility Treatments Cryobanks , by Region USD Million (2025-2030)
  • Table 222. Fertility Treatments: by Sex(USD Million)
  • Table 223. Fertility Treatments Male , by Region USD Million (2025-2030)
  • Table 224. Fertility Treatments Female , by Region USD Million (2025-2030)
  • Table 225. Fertility Treatments: by Procedure(USD Million)
  • Table 226. Fertility Treatments Assisted Reproductive Technology (Vitro Fertilization, Surrogacy, and Intra-Cytoplasmic Sperm Injection (ICSI)) , by Region USD Million (2025-2030)
  • Table 227. Fertility Treatments Artificial Insemination (Intrauterine Insemination, Intracervical Insemination, and Intratubal Insemination) , by Region USD Million (2025-2030)
  • Table 228. Fertility Treatments Fertility Surgery (Myomectomy, Laparoscopy, Hysteroscopy, Varicocelectomy, Laparotomy, Tubal Ligation Reversal, and Microsurgical Reconstruction) , by Region USD Million (2025-2030)
  • Table 229. Fertility Treatments Others , by Region USD Million (2025-2030)
  • Table 230. Fertility Treatments: by Diagnostic Centers(USD Million)
  • Table 231. Fertility Treatments Men Diagnostic Tests , by Region USD Million (2025-2030)
  • Table 232. Fertility Treatments Women Diagnostic , by Region USD Million (2025-2030)
  • Table 233. Fertility Treatments General Diagnostic Tests , by Region USD Million (2025-2030)
  • Table 234. South America Fertility Treatments, by Country USD Million (2025-2030)
  • Table 235. South America Fertility Treatments, by Type USD Million (2025-2030)
  • Table 236. South America Fertility Treatments, by End Users USD Million (2025-2030)
  • Table 237. South America Fertility Treatments, by Sex USD Million (2025-2030)
  • Table 238. South America Fertility Treatments, by Procedure USD Million (2025-2030)
  • Table 239. South America Fertility Treatments, by Diagnostic Centers USD Million (2025-2030)
  • Table 240. Brazil Fertility Treatments, by Type USD Million (2025-2030)
  • Table 241. Brazil Fertility Treatments, by End Users USD Million (2025-2030)
  • Table 242. Brazil Fertility Treatments, by Sex USD Million (2025-2030)
  • Table 243. Brazil Fertility Treatments, by Procedure USD Million (2025-2030)
  • Table 244. Brazil Fertility Treatments, by Diagnostic Centers USD Million (2025-2030)
  • Table 245. Argentina Fertility Treatments, by Type USD Million (2025-2030)
  • Table 246. Argentina Fertility Treatments, by End Users USD Million (2025-2030)
  • Table 247. Argentina Fertility Treatments, by Sex USD Million (2025-2030)
  • Table 248. Argentina Fertility Treatments, by Procedure USD Million (2025-2030)
  • Table 249. Argentina Fertility Treatments, by Diagnostic Centers USD Million (2025-2030)
  • Table 250. Chile Fertility Treatments, by Type USD Million (2025-2030)
  • Table 251. Chile Fertility Treatments, by End Users USD Million (2025-2030)
  • Table 252. Chile Fertility Treatments, by Sex USD Million (2025-2030)
  • Table 253. Chile Fertility Treatments, by Procedure USD Million (2025-2030)
  • Table 254. Chile Fertility Treatments, by Diagnostic Centers USD Million (2025-2030)
  • Table 255. Rest of South America Fertility Treatments, by Type USD Million (2025-2030)
  • Table 256. Rest of South America Fertility Treatments, by End Users USD Million (2025-2030)
  • Table 257. Rest of South America Fertility Treatments, by Sex USD Million (2025-2030)
  • Table 258. Rest of South America Fertility Treatments, by Procedure USD Million (2025-2030)
  • Table 259. Rest of South America Fertility Treatments, by Diagnostic Centers USD Million (2025-2030)
  • Table 260. Asia Pacific Fertility Treatments, by Country USD Million (2025-2030)
  • Table 261. Asia Pacific Fertility Treatments, by Type USD Million (2025-2030)
  • Table 262. Asia Pacific Fertility Treatments, by End Users USD Million (2025-2030)
  • Table 263. Asia Pacific Fertility Treatments, by Sex USD Million (2025-2030)
  • Table 264. Asia Pacific Fertility Treatments, by Procedure USD Million (2025-2030)
  • Table 265. Asia Pacific Fertility Treatments, by Diagnostic Centers USD Million (2025-2030)
  • Table 266. China Fertility Treatments, by Type USD Million (2025-2030)
  • Table 267. China Fertility Treatments, by End Users USD Million (2025-2030)
  • Table 268. China Fertility Treatments, by Sex USD Million (2025-2030)
  • Table 269. China Fertility Treatments, by Procedure USD Million (2025-2030)
  • Table 270. China Fertility Treatments, by Diagnostic Centers USD Million (2025-2030)
  • Table 271. Japan Fertility Treatments, by Type USD Million (2025-2030)
  • Table 272. Japan Fertility Treatments, by End Users USD Million (2025-2030)
  • Table 273. Japan Fertility Treatments, by Sex USD Million (2025-2030)
  • Table 274. Japan Fertility Treatments, by Procedure USD Million (2025-2030)
  • Table 275. Japan Fertility Treatments, by Diagnostic Centers USD Million (2025-2030)
  • Table 276. India Fertility Treatments, by Type USD Million (2025-2030)
  • Table 277. India Fertility Treatments, by End Users USD Million (2025-2030)
  • Table 278. India Fertility Treatments, by Sex USD Million (2025-2030)
  • Table 279. India Fertility Treatments, by Procedure USD Million (2025-2030)
  • Table 280. India Fertility Treatments, by Diagnostic Centers USD Million (2025-2030)
  • Table 281. South Korea Fertility Treatments, by Type USD Million (2025-2030)
  • Table 282. South Korea Fertility Treatments, by End Users USD Million (2025-2030)
  • Table 283. South Korea Fertility Treatments, by Sex USD Million (2025-2030)
  • Table 284. South Korea Fertility Treatments, by Procedure USD Million (2025-2030)
  • Table 285. South Korea Fertility Treatments, by Diagnostic Centers USD Million (2025-2030)
  • Table 286. Singapore Fertility Treatments, by Type USD Million (2025-2030)
  • Table 287. Singapore Fertility Treatments, by End Users USD Million (2025-2030)
  • Table 288. Singapore Fertility Treatments, by Sex USD Million (2025-2030)
  • Table 289. Singapore Fertility Treatments, by Procedure USD Million (2025-2030)
  • Table 290. Singapore Fertility Treatments, by Diagnostic Centers USD Million (2025-2030)
  • Table 291. Indonesia Fertility Treatments, by Type USD Million (2025-2030)
  • Table 292. Indonesia Fertility Treatments, by End Users USD Million (2025-2030)
  • Table 293. Indonesia Fertility Treatments, by Sex USD Million (2025-2030)
  • Table 294. Indonesia Fertility Treatments, by Procedure USD Million (2025-2030)
  • Table 295. Indonesia Fertility Treatments, by Diagnostic Centers USD Million (2025-2030)
  • Table 296. Thailand Fertility Treatments, by Type USD Million (2025-2030)
  • Table 297. Thailand Fertility Treatments, by End Users USD Million (2025-2030)
  • Table 298. Thailand Fertility Treatments, by Sex USD Million (2025-2030)
  • Table 299. Thailand Fertility Treatments, by Procedure USD Million (2025-2030)
  • Table 300. Thailand Fertility Treatments, by Diagnostic Centers USD Million (2025-2030)
  • Table 301. Australia Fertility Treatments, by Type USD Million (2025-2030)
  • Table 302. Australia Fertility Treatments, by End Users USD Million (2025-2030)
  • Table 303. Australia Fertility Treatments, by Sex USD Million (2025-2030)
  • Table 304. Australia Fertility Treatments, by Procedure USD Million (2025-2030)
  • Table 305. Australia Fertility Treatments, by Diagnostic Centers USD Million (2025-2030)
  • Table 306. Rest of Asia-Pacific Fertility Treatments, by Type USD Million (2025-2030)
  • Table 307. Rest of Asia-Pacific Fertility Treatments, by End Users USD Million (2025-2030)
  • Table 308. Rest of Asia-Pacific Fertility Treatments, by Sex USD Million (2025-2030)
  • Table 309. Rest of Asia-Pacific Fertility Treatments, by Procedure USD Million (2025-2030)
  • Table 310. Rest of Asia-Pacific Fertility Treatments, by Diagnostic Centers USD Million (2025-2030)
  • Table 311. Europe Fertility Treatments, by Country USD Million (2025-2030)
  • Table 312. Europe Fertility Treatments, by Type USD Million (2025-2030)
  • Table 313. Europe Fertility Treatments, by End Users USD Million (2025-2030)
  • Table 314. Europe Fertility Treatments, by Sex USD Million (2025-2030)
  • Table 315. Europe Fertility Treatments, by Procedure USD Million (2025-2030)
  • Table 316. Europe Fertility Treatments, by Diagnostic Centers USD Million (2025-2030)
  • Table 317. Germany Fertility Treatments, by Type USD Million (2025-2030)
  • Table 318. Germany Fertility Treatments, by End Users USD Million (2025-2030)
  • Table 319. Germany Fertility Treatments, by Sex USD Million (2025-2030)
  • Table 320. Germany Fertility Treatments, by Procedure USD Million (2025-2030)
  • Table 321. Germany Fertility Treatments, by Diagnostic Centers USD Million (2025-2030)
  • Table 322. France Fertility Treatments, by Type USD Million (2025-2030)
  • Table 323. France Fertility Treatments, by End Users USD Million (2025-2030)
  • Table 324. France Fertility Treatments, by Sex USD Million (2025-2030)
  • Table 325. France Fertility Treatments, by Procedure USD Million (2025-2030)
  • Table 326. France Fertility Treatments, by Diagnostic Centers USD Million (2025-2030)
  • Table 327. Italy Fertility Treatments, by Type USD Million (2025-2030)
  • Table 328. Italy Fertility Treatments, by End Users USD Million (2025-2030)
  • Table 329. Italy Fertility Treatments, by Sex USD Million (2025-2030)
  • Table 330. Italy Fertility Treatments, by Procedure USD Million (2025-2030)
  • Table 331. Italy Fertility Treatments, by Diagnostic Centers USD Million (2025-2030)
  • Table 332. United Kingdom Fertility Treatments, by Type USD Million (2025-2030)
  • Table 333. United Kingdom Fertility Treatments, by End Users USD Million (2025-2030)
  • Table 334. United Kingdom Fertility Treatments, by Sex USD Million (2025-2030)
  • Table 335. United Kingdom Fertility Treatments, by Procedure USD Million (2025-2030)
  • Table 336. United Kingdom Fertility Treatments, by Diagnostic Centers USD Million (2025-2030)
  • Table 337. Netherlands Fertility Treatments, by Type USD Million (2025-2030)
  • Table 338. Netherlands Fertility Treatments, by End Users USD Million (2025-2030)
  • Table 339. Netherlands Fertility Treatments, by Sex USD Million (2025-2030)
  • Table 340. Netherlands Fertility Treatments, by Procedure USD Million (2025-2030)
  • Table 341. Netherlands Fertility Treatments, by Diagnostic Centers USD Million (2025-2030)
  • Table 342. Spain Fertility Treatments, by Type USD Million (2025-2030)
  • Table 343. Spain Fertility Treatments, by End Users USD Million (2025-2030)
  • Table 344. Spain Fertility Treatments, by Sex USD Million (2025-2030)
  • Table 345. Spain Fertility Treatments, by Procedure USD Million (2025-2030)
  • Table 346. Spain Fertility Treatments, by Diagnostic Centers USD Million (2025-2030)
  • Table 347. Sweden Fertility Treatments, by Type USD Million (2025-2030)
  • Table 348. Sweden Fertility Treatments, by End Users USD Million (2025-2030)
  • Table 349. Sweden Fertility Treatments, by Sex USD Million (2025-2030)
  • Table 350. Sweden Fertility Treatments, by Procedure USD Million (2025-2030)
  • Table 351. Sweden Fertility Treatments, by Diagnostic Centers USD Million (2025-2030)
  • Table 352. Belgium Fertility Treatments, by Type USD Million (2025-2030)
  • Table 353. Belgium Fertility Treatments, by End Users USD Million (2025-2030)
  • Table 354. Belgium Fertility Treatments, by Sex USD Million (2025-2030)
  • Table 355. Belgium Fertility Treatments, by Procedure USD Million (2025-2030)
  • Table 356. Belgium Fertility Treatments, by Diagnostic Centers USD Million (2025-2030)
  • Table 357. Finland Fertility Treatments, by Type USD Million (2025-2030)
  • Table 358. Finland Fertility Treatments, by End Users USD Million (2025-2030)
  • Table 359. Finland Fertility Treatments, by Sex USD Million (2025-2030)
  • Table 360. Finland Fertility Treatments, by Procedure USD Million (2025-2030)
  • Table 361. Finland Fertility Treatments, by Diagnostic Centers USD Million (2025-2030)
  • Table 362. Denmark Fertility Treatments, by Type USD Million (2025-2030)
  • Table 363. Denmark Fertility Treatments, by End Users USD Million (2025-2030)
  • Table 364. Denmark Fertility Treatments, by Sex USD Million (2025-2030)
  • Table 365. Denmark Fertility Treatments, by Procedure USD Million (2025-2030)
  • Table 366. Denmark Fertility Treatments, by Diagnostic Centers USD Million (2025-2030)
  • Table 367. Russia Fertility Treatments, by Type USD Million (2025-2030)
  • Table 368. Russia Fertility Treatments, by End Users USD Million (2025-2030)
  • Table 369. Russia Fertility Treatments, by Sex USD Million (2025-2030)
  • Table 370. Russia Fertility Treatments, by Procedure USD Million (2025-2030)
  • Table 371. Russia Fertility Treatments, by Diagnostic Centers USD Million (2025-2030)
  • Table 372. Rest of Europe Fertility Treatments, by Type USD Million (2025-2030)
  • Table 373. Rest of Europe Fertility Treatments, by End Users USD Million (2025-2030)
  • Table 374. Rest of Europe Fertility Treatments, by Sex USD Million (2025-2030)
  • Table 375. Rest of Europe Fertility Treatments, by Procedure USD Million (2025-2030)
  • Table 376. Rest of Europe Fertility Treatments, by Diagnostic Centers USD Million (2025-2030)
  • Table 377. MEA Fertility Treatments, by Country USD Million (2025-2030)
  • Table 378. MEA Fertility Treatments, by Type USD Million (2025-2030)
  • Table 379. MEA Fertility Treatments, by End Users USD Million (2025-2030)
  • Table 380. MEA Fertility Treatments, by Sex USD Million (2025-2030)
  • Table 381. MEA Fertility Treatments, by Procedure USD Million (2025-2030)
  • Table 382. MEA Fertility Treatments, by Diagnostic Centers USD Million (2025-2030)
  • Table 383. Middle East Fertility Treatments, by Type USD Million (2025-2030)
  • Table 384. Middle East Fertility Treatments, by End Users USD Million (2025-2030)
  • Table 385. Middle East Fertility Treatments, by Sex USD Million (2025-2030)
  • Table 386. Middle East Fertility Treatments, by Procedure USD Million (2025-2030)
  • Table 387. Middle East Fertility Treatments, by Diagnostic Centers USD Million (2025-2030)
  • Table 388. Africa Fertility Treatments, by Type USD Million (2025-2030)
  • Table 389. Africa Fertility Treatments, by End Users USD Million (2025-2030)
  • Table 390. Africa Fertility Treatments, by Sex USD Million (2025-2030)
  • Table 391. Africa Fertility Treatments, by Procedure USD Million (2025-2030)
  • Table 392. Africa Fertility Treatments, by Diagnostic Centers USD Million (2025-2030)
  • Table 393. North America Fertility Treatments, by Country USD Million (2025-2030)
  • Table 394. North America Fertility Treatments, by Type USD Million (2025-2030)
  • Table 395. North America Fertility Treatments, by End Users USD Million (2025-2030)
  • Table 396. North America Fertility Treatments, by Sex USD Million (2025-2030)
  • Table 397. North America Fertility Treatments, by Procedure USD Million (2025-2030)
  • Table 398. North America Fertility Treatments, by Diagnostic Centers USD Million (2025-2030)
  • Table 399. United States Fertility Treatments, by Type USD Million (2025-2030)
  • Table 400. United States Fertility Treatments, by End Users USD Million (2025-2030)
  • Table 401. United States Fertility Treatments, by Sex USD Million (2025-2030)
  • Table 402. United States Fertility Treatments, by Procedure USD Million (2025-2030)
  • Table 403. United States Fertility Treatments, by Diagnostic Centers USD Million (2025-2030)
  • Table 404. Canada Fertility Treatments, by Type USD Million (2025-2030)
  • Table 405. Canada Fertility Treatments, by End Users USD Million (2025-2030)
  • Table 406. Canada Fertility Treatments, by Sex USD Million (2025-2030)
  • Table 407. Canada Fertility Treatments, by Procedure USD Million (2025-2030)
  • Table 408. Canada Fertility Treatments, by Diagnostic Centers USD Million (2025-2030)
  • Table 409. Mexico Fertility Treatments, by Type USD Million (2025-2030)
  • Table 410. Mexico Fertility Treatments, by End Users USD Million (2025-2030)
  • Table 411. Mexico Fertility Treatments, by Sex USD Million (2025-2030)
  • Table 412. Mexico Fertility Treatments, by Procedure USD Million (2025-2030)
  • Table 413. Mexico Fertility Treatments, by Diagnostic Centers USD Million (2025-2030)
  • Table 414. Research Programs/Design for This Report
  • Table 415. Key Data Information from Secondary Sources
  • Table 416. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Fertility Treatments: by Type USD Million (2018-2023)
  • Figure 5. Global Fertility Treatments: by End Users USD Million (2018-2023)
  • Figure 6. Global Fertility Treatments: by Sex USD Million (2018-2023)
  • Figure 7. Global Fertility Treatments: by Procedure USD Million (2018-2023)
  • Figure 8. Global Fertility Treatments: by Diagnostic Centers USD Million (2018-2023)
  • Figure 9. South America Fertility Treatments Share (%), by Country
  • Figure 10. Asia Pacific Fertility Treatments Share (%), by Country
  • Figure 11. Europe Fertility Treatments Share (%), by Country
  • Figure 12. MEA Fertility Treatments Share (%), by Country
  • Figure 13. North America Fertility Treatments Share (%), by Country
  • Figure 14. Global Fertility Treatments share by Players 2023 (%)
  • Figure 15. Global Fertility Treatments share by Players (Top 3) 2023(%)
  • Figure 16. Global Fertility Treatments share by Players (Top 5) 2023(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Cook Group Incorporated (United States) Revenue, Net Income and Gross profit
  • Figure 19. Cook Group Incorporated (United States) Revenue: by Geography 2023
  • Figure 20. Esco Micro Pte. Ltd. (Singapore) Revenue, Net Income and Gross profit
  • Figure 21. Esco Micro Pte. Ltd. (Singapore) Revenue: by Geography 2023
  • Figure 22. Genea Limited (Australia) Revenue, Net Income and Gross profit
  • Figure 23. Genea Limited (Australia) Revenue: by Geography 2023
  • Figure 24. Hamilton Throne, Ltd. (United States) Revenue, Net Income and Gross profit
  • Figure 25. Hamilton Throne, Ltd. (United States) Revenue: by Geography 2023
  • Figure 26. Ihmedical (United States) Revenue, Net Income and Gross profit
  • Figure 27. Ihmedical (United States) Revenue: by Geography 2023
  • Figure 28. Irvine Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 29. Irvine Scientific (United States) Revenue: by Geography 2023
  • Figure 30. IVFTech Aps (Denmark) Revenue, Net Income and Gross profit
  • Figure 31. IVFTech Aps (Denmark) Revenue: by Geography 2023
  • Figure 32. Kitazato Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 33. Kitazato Corporation (Japan) Revenue: by Geography 2023
  • Figure 34. Medgyn Products, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 35. Medgyn Products, Inc. (United States) Revenue: by Geography 2023
  • Figure 36. Rocket Medical PLC (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 37. Rocket Medical PLC (United Kingdom) Revenue: by Geography 2023
  • Figure 38. Somatex Medical Technologies GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 39. Somatex Medical Technologies GmbH (Germany) Revenue: by Geography 2023
  • Figure 40. Global Fertility Treatments: by Type USD Million (2025-2030)
  • Figure 41. Global Fertility Treatments: by End Users USD Million (2025-2030)
  • Figure 42. Global Fertility Treatments: by Sex USD Million (2025-2030)
  • Figure 43. Global Fertility Treatments: by Procedure USD Million (2025-2030)
  • Figure 44. Global Fertility Treatments: by Diagnostic Centers USD Million (2025-2030)
  • Figure 45. South America Fertility Treatments Share (%), by Country
  • Figure 46. Asia Pacific Fertility Treatments Share (%), by Country
  • Figure 47. Europe Fertility Treatments Share (%), by Country
  • Figure 48. MEA Fertility Treatments Share (%), by Country
  • Figure 49. North America Fertility Treatments Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Cook Group Incorporated (United States)
  • Esco Micro Pte. Ltd. (Singapore)
  • Genea Limited (Australia)
  • Hamilton Throne, Ltd. (United States)
  • Ihmedical (United States)
  • Irvine Scientific (United States)
  • IVFTech Aps (Denmark)
  • Kitazato Corporation (Japan)
  • Medgyn Products, Inc. (United States)
  • Rocket Medical PLC (United Kingdom)
  • Somatex Medical Technologies GmbH (Germany)
Additional players considered in the study are as follows:
The Baker Company, Inc. (United States) , The Cooper Companies, Inc. (United States) , Thermo Fisher Scientific (United States) , Vitrolife Ab (Sweden) , Zeiss Group (Germany)
Select User Access Type

Key Highlights of Report


Apr 2024 244 Pages 78 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Fertility Treatments Market Quantitative research analysis
Global Fertility Treatments Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Fertility Treatments Market are by type [Equipment (Microscopes, Sperm Analyzer Systems, Imaging Systems, Micromanipulators Systems, Ovum Aspiration Pumps, Cryosystems, Incubators, Gas Analyzers, and Laser Systems), Consumables and Accessories], by end use application [].
The Fertility Treatments Market is gaining popularity and expected to see strong valuation by 2030.
  • Declining Fertility Rate
  • Increasing Awareness Among People
  • Increasing Disposable Income
  • Rising Adoption of Assisted Reproductive Technologies (ART)
  • Growing Sedentary Lifestyle across the Globe

Know More About Global Fertility Treatments Market Report?

Have a Query? Click Here

Other Related Reports

Skin Tears Treatment Comprehensive Study by Type (Moisture-retentive Dressing(Meah Dressing, Foam Dressing, Hydrogel Dressing, Silicone Dressing, Alginate Dressing, Acrilic Dressing, Hydrocolloidal D...
$ 3750
Dental Infection Prevention Comprehensive Study by Type (Gloves, Masks, Eyewear, Single-Use Disposable Dental Tools, Others), End Users (Dental Hospitals and Clinics, Dental Academic and Research Ins...
$ 3650
Compartment Syndrome Monitoring Comprehensive Study by Type (Acute Compartment Syndrome, Chronic Compartment Syndrome), Application (Head Trauma, Abdominal Hypertension, Muscle Injury), End User (Hos...
$ 3350
Std Self Diagnostics Comprehensive Study by Type (Testing Kit, Testing Device, Testing Strip/chip), Application (Hospitals, Homecare, Diagnostic Centres, Others), Usability (Reusable, Disposable), Te...
$ 3650
Microbiological Testing Service Comprehensive Study by Application (Clinical Disease Diagnostics, Food & Beverage testing, Pharmaceutical & Biological Drug Testing, Environmental Testing, Cosmetics a...
$ 3750
Personal Genome Services Comprehensive Study by Application (Drug Discovery and Development, Diagnostics, Agriculture and Animal Research, Other), Technology (Sequencing, PCR, Nucleic Acid Extraction...
$ 3750